drug-discovery

To calculate drug-likeness, provide a compound or target name to fetch public data and compute standardized metrics like Ro5, QED, TPSA, and synthetic accessibility. The workflow extracts compound information from open sources and returns actionable property summaries.

You can search ChEMBL for bioactive compounds by asking the workflow to analyze a specific target, activity, or molecule name. It queries open data sources to identify and interpret bioactive compounds, returning results with citations for medicinal chemistry research.

Interpreting ADMET data and checking drug interactions involves querying OpenFDA for interaction lookups and OpenTargets for target-disease associations. The workflow analyzes this public data to provide ADMET interpretation and lead-optimization suggestions.

Yes, you can use open data sources like PubChem, ChEMBL, OpenFDA, and OpenTargets for pharmaceutical research without paid APIs. The workflow integrates multiple free APIs to compute standardized metrics and return outputs with citations and safety notes.

Finding target-disease associations is best done by querying OpenTargets context within a consolidated workflow. This approach integrates free APIs to identify bioactive compounds and provide ADMET interpretation and lead-optimization guidance.

Limitations of using open data workflows include reliance on public database coverage and the need for safety note interpretation. The workflow returns actionable outputs with citations, but users must manually verify lead-optimization suggestions for real-world pharmaceutical research.